Article Details
Retrieved on: 2021-04-01 14:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The commercial supply agreement includes manufacturing of the mRNA drug substance as well as lipid nanoparticle (LNP) formulation of the bulk drug ...
Article found on: www.europeanpharmaceuticalreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here